Top 10 stocks for today — 31st October 2022

31 Oct 2022 , 08:29 AM

The Singapore Exchange’s Nifty futures traded 193.5 points, or 1.08%, higher at 18,028, indicating that the stock market may begin the day higher on Monday. The following stocks may show price movement in today’s trade. Check more hot stocks at: https://www.indiainfoline.com/markets/hot-stocks

1. Maruti Suzuki:

Due to record sales, the automaker’s consolidated net profit after tax increased by more than four times to Rs 2,112.5 crore in the second quarter.

1. Vedanta:

Due to increasing expenses, mining firm Vedanta recorded a consolidated net profit after tax that fell by 53% to Rs 2690 crore for the three months that ended on September 30.

1. Blue Dart:

On a consolidated basis, the company recorded a growth in total revenues of 17.95%, or Rs 1,325 crore, for the quarter ending in September 2022.

1. NTPC:

Due to rising expenses, the state-run power company NTPC reported a more than 7% decline in its consolidated net profit for the September quarter of FY23, coming in at Rs 3,417.67 crore.

1. Lupin:

The Nagpur Unit-2 injectable production facility of Lupin was inspected by the US FDA. A Pre-Approval Inspection (PAI) of the injectable facility was conducted.

1. Hindustan Copper:

The company’s Long-term rating of ICRA AA+ and Short-term rating of ICRA A1+ have both been reaffirmed by credit rating agency ICRA. The Long-Term Rating’s outlook is stable.

1. Bandhan Bank:

Compared to a loss of Rs3,009 crore in the same period last year, Bandhan Bank, a private company, declared a net profit of Rs 209 crore for the third quarter.

1. Hero MotoCorp:

Hero MotoCorp, the largest two-wheeler manufacturer in the nation, reported significant double-digit growth in retail sales during the holiday season.

1. Zydus Lifesciences:

The US Food and Drug Administration (USFDA) has given the business final permission to commercialise acetaminophen injection’s 1,000 mg/100mL (10 mg/mL) single-dose vials.

1. Dr Reddy’s Laboratories:

For the quarter that ended in September, Dr Reddy’s Laboratories recorded a roughly 12% year-over-year (YoY) increase in consolidated net profit at Rs1,114 crore.

For feedback and suggestions, write to us at [e-mail]